Key Takeaways:
Up to 319 million SpaceX insider shares become eligible for sale Sept. 9, the first of five staged lockup releases through Dec. 8.
"When less selling pressure emerges than expected, the price sometimes even rises on a release; usually it falls, but not always," Jay Ritter, professor emeritus at the University of Florida and a specialist in listings, said.
The release is the second stage of a 180-day lockup written into the prospectus SpaceX filed with the US Securities and Exchange Commission on June 12, the day it raised $85.7 billion in the largest IPO on record. The first stage on Aug. 6 freed up to 911.5 million shares, about 20 percent of the pool, which CNN reported at roughly 4.56 billion shares. Each subsequent stage releases about 7 percent, or roughly 320 million shares.
The five releases through Dec. 8 will expand the freely tradable float from about 4 percent at listing toward roughly 40 percent of the company, adding supply that early shareholders can sell. Founder shares, held by Elon Musk, stay locked until June 12, 2027, under a separate 366-day agreement.
The staged structure departs from a conventional single-cliff unlock. SpaceX split the 180-day pool into tranches of 7 percent roughly every two weeks, with a larger release tied to third-quarter results and the remainder due Dec. 8. A separate group of large shareholders agreed to an extended lockup ending after second-quarter 2027 results, and the founder's shares carry no early release.
The first release offered a preview of how the market absorbs the supply. On Aug. 5, the day before, the stock fell almost 14 percent to close at $108.27, an all-time low, according to CNN. On Aug. 6, when up to 911.5 million shares became eligible, the price rose more than 6 percent, as retail investors bought on net every trading day, Viraj Patel of Vanda said.
The stock has traded well below its offer price of $135 since the first release, and the additional 10 percent stage tied to third-quarter results would have required a price at least 30 percent above the offer, a mark that was out of reach with the stock near $108. The next earnings report, due Sept. 2, and the quarterly Nasdaq 100 rebalancing in September will shape demand before the Sept. 9 release.
For holders, the Sept. 9 release is a supply event, not a verdict on the business. Investors will watch whether the stock repeats the Aug. 6 pattern of relief after the date, and the Dec. 8 final release as the next major test of the float.
This article is for informational purposes only and does not constitute investment advice.
